Status:
COMPLETED
Screening for Hearing Loss After Childhood Cancer
Lead Sponsor:
University of Bern
Collaborating Sponsors:
Krebsforschung Schweiz, Bern, Switzerland
Conditions:
Childhood Cancer
Hearing Loss
Eligibility:
All Genders
18+ years
Phase:
NA
Brief Summary
The HEAR-study pilots and evaluates a national, low-threshold screening program to detect hearing problems in Swiss adult childhood cancer survivors. Participants will conduct a hearing test in a loc...
Detailed Description
Hearing loss is an adverse event in childhood cancer survivors (CCS). It is caused by ototoxic cancer treatments, in particular platinum chemotherapy, cranial radiation with doses of ≥30 Gray, and sur...
Eligibility Criteria
Inclusion
- Diagnosed with childhood cancer according to the international classification of childhood cancer, edition 3 (ICCC3) main groups
- Diagnosed before the age 21
- Diagnosed in Switzerland
- Registered in the Swiss Childhood Cancer Registry
- Recovered \& survived ≥2 years after diagnosis
- Diagnosed between 1976-2019
- Treated in one of the clinics of the Swiss Paediatric Oncology Group
- Exposed to any chemotherapy and/or radiation to the head, neck or spine (TBI included)
- Written informed consent
Exclusion
- Recently contacted for other studies (January 2022-July 2022)
- Not German/French speaking
- No postal address available
Key Trial Info
Start Date :
July 5 2022
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
November 1 2024
Estimated Enrollment :
476 Patients enrolled
Trial Details
Trial ID
NCT06036407
Start Date
July 5 2022
End Date
November 1 2024
Last Update
May 30 2025
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Institute for Social and Preventive Medicine
Bern, Switzerland, 3012